Meeting
2013 ASCO Annual Meeting
Aspirin use and survival outcomes in patients (pts) with PIK3CA mutant colorectal cancer (CRC).
Authors
Ben Tran
Royal Melbourne Hospital, Melbourne, Australia
Ben Tran , Robert N Jorissen , Jayesh Desai , Fiona Day , Lara Rachel Lipton , Hui-Li Wong , Jeanne Tie , Ian Faragher , Ian Jones , Oliver Sieber , Peter Gibbs
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 3598)
DOI
10.1200/jco.2013.31.15_suppl.3598
Abstract #
3598
Poster Bd #
8H
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Prognostic and predictive values of APC and WNT pathway mutations in MSS colorectal cancers.
First Author: Nishi Kothari
Poster
2013 ASCO Annual Meeting
Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation.
First Author: Nishi Kothari
First Author: Wei-li Ma
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Temsirolimus (T) in patients (pts) with colorectal cancer (CRC) with PIK3CA mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
First Author: Jean L. Grem